Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report - Top-Institutions - MDSpire

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report

  • By

  • Parham Habibzadeh

  • Anushri Kulkarni

  • Drew Hurd

  • Amy Rose

  • Danielle Bednarz

  • Yana G. Najjar

  • John M. Kirkwood

  • Arivarasan Karunamurthy

  • Diwakar Davar

  • July 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Melanoma

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Melanoma

Original Source(s)

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report

  • by Parham Habibzadeh, Anushri Kulkarni, Drew Hurd, Amy Rose, Danielle Bednarz, Yana G. Najjar, John M. Kirkwood, Arivarasan Karunamurthy, Diwakar Davar

  • July 2, 2026

Related Content

Integrating anisotropic heat flow and transformer encoders in convolutional neural network for skin cancer classification

Association between tumor genomic mutations and the risk of PD-1 inhibitor-induced hypophysitis: a retrospective cohort study

Generation of functional canine TIL products for solid tumors